{
  "main_header": {
    "sid": 1103879,
    "name": "Gulf Pharmaceutical Industries",
    "stock_name": "Gulf Pharmaceutical Industries",
    "full_name": "Gulf Pharmaceutical Industries",
    "name_url": "stocks-analysis/gulf-pharmaceutical-industries",
    "exchange": 1,
    "exchangecode": "ADS",
    "country_id": 76,
    "currency": "AED",
    "cmp": "1.23",
    "chg": -0.02,
    "chgp": "-1.6%",
    "dir": -1,
    "prev_price": "1.25",
    "mcapval": "1,409.38",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "Abu Dhabi Securities Exchange",
    "isin": "AEG000201018",
    "curr_date": "Dec 12",
    "curr_time": "",
    "bse_nse_vol": "7.78 M",
    "exc_status": "Active",
    "traded_date": "Dec 12, 2025",
    "traded_date_str": "2025 12 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gulf-pharmaceutical-industries-1103879-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gulf Pharmaceutical Industries Reports Mixed Financial Results Amidst Growth in Key Metrics",
        "link": "https://www.marketsmojo.com/news/mojo-premium/gulf-pharmaceutical-industries-joins-reliable-performers-strategy-amidst-mixed-financial-results-3588260",
        "imagepath": "",
        "date": "2025-10-02 22:23:36",
        "description": "<p><strong>Gulf Pharmaceutical Industries</strong>, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial performance for the quarter ending June 2025. The results indicate a challenging financial landscape, with very negative overall performance noted for the period.</p>\n\n<p>Despite the overall negative performance, several key metrics show promising growth. The operating cash flow reached its highest level at AED 145.7 MM, indicating strong liquidity management. Additionally, the return on capital employed (ROCE) for the half-year stands at 6.2%, reflecting effective utilization of capital.</p>\n\n<p>One notable aspect of <strong>Gulf Pharmaceutical Industries</strong>' financials is its interest coverage ratio, which suggests that the company has minimal interest costs. This positions the company favorably in terms of financial stability. Furthermore, the raw..."
      }
    ],
    "total": 1,
    "sid": "1103879",
    "stock_news_url": "https://www.marketsmojo.com/news/gulf-pharmaceutical-industries-1103879"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Gulf Pharmaceutical Industries Reports Mixed Financial Results Amidst Growth in Key Metrics

2025-10-02 22:23:36

Gulf Pharmaceutical Industries, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial performance for the quarter ending June 2025. The results indicate a challenging financial landscape, with very negative overall performance noted for the period.

Despite the overall negative performance, several key metrics show promising growth. The operating cash flow reached its highest level at AED 145.7 MM, indicating strong liquidity management. Additionally, the return on capital employed (ROCE) for the half-year stands at 6.2%, reflecting effective utilization of capital.

One notable aspect of Gulf Pharmaceutical Industries' financials is its interest coverage ratio, which suggests that the company has minimal interest costs. This positions the company favorably in terms of financial stability. Furthermore, the raw...

Read More

View All News